Lab-on-a-Chip - The Online Scientific Community

Dolomite Announces Record Growth in 2010
Tuesday, April 26, 2011
Dolomite has fast become the world leader in the design and manufacture of microfluidic solutions including chips, pumps, and custom devices.

HP Speeds Drug Discovery Research with Inkjet Technology
Tuesday, April 26, 2011
HP announced an innovative drug research application for its inkjet technology that enables pharmaceutical companies to more efficiently develop better drugs through vastly more precise dispensing of dosages.

New Optical Sorting Technique Developed at St Andrews
Tuesday, April 26, 2011
A new optical microfluidic sorting technique developed at the University of St Andrews will allow biological or other matter to be sorted or fractionated by criteria including size, shape, density and refractive index.

Caliper's Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
Tuesday, April 26, 2011
Wako diagnostics obtains 510(k) FDA clearance to market its uTASWako® i30 immunoanalyzer system in the U.S. to clinical laboratories.

Fluidigm System Helps Identify Cancer Biomarkers
Monday, April 25, 2011
UCSF researchers have identified serum microRNAs by using Fluidigm Corporation's BioMark™ System and Digital Array™ IFCs.

Ambry Genetics Adds Certification of Roche NimbleGen CGH, DNA Methylation, Gene Expression, and ChIP-chip to Service Portfolio
Wednesday, April 20, 2011
Ambry Genetics is now certified on all Roche NimbleGen applications and will process samples for copy number variation, DNA methylation analysis and chromatin structure.

Caliper's Microfluidic Technologies Enable 510(k) Approved Multiplexed Immunoassay System for Liver Cancer Risk Assessment
Wednesday, April 20, 2011
Wako diagnostics obtains 510(k) FDA clearance to market its uTASWako® i30 immunoanalyzer system in the U.S. to clinical laboratories.

Precise & Accurate Measurement of Target Copy Number
Sunday, April 17, 2011
New 200k chip prototype is more powerful and enables an even more precise and accurate measurement of target copy number.

Fluidigm Access Array Technology Helps Identify Mutations in Leukemia
Friday, April 15, 2011
Access Array™ technology uncover mutations in chronic myelomonocytic leukemia patients, providing new insights into the molecular heterogeneity of the disease.

<<	10 11 12 13 14 15 16	>>
Showing Results 121 - 130 of 1011

Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.

FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.

Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.